Wednesday, September 30, 2009

Mkt, Biotech Edges Down Wed 9.30

Wednesday 9.30.09:
DOW -47(.5%) @9,742..NAS -6.7(.3%) @2,124..SP500 -2.4(.2%) @1,060

BIO-Stem Index:-.60(-.4%) @144.63 (+44.64% ytd)
BIO-ETF Index:-.76(-.66%) @114.38 (+14.38% ytd)

The market fell a fractional amount again Wednesday, but erased an early 100 pt drop in the Dow (does anyone besides the media watch that anymore?). APT jumped 17% when they said they are running their plant 24/7 to keep up with demand for face masks and respirators. DSCO jumped 22% after an FDA meeting allows them to go ahead with drug testing (three years of this so far - the FDA games never end as they are owned by big pharma).

Stem Cell Stocks (10 up, 21 down)
Big Winners:AVII +10.3%, NUVA +3.6%
Losers: ASTM -9.2%, CUR -7.1%, OSTE -10.8%, SQNM -6.7% (the slide continues for them)

Swine Flu Stocks
AVII +10.3%, BCRX +.7% (up big after hrs, something may be up), DVAX -2.1%, GILD +.04%, INHX +1.1%, INO -1.9%, NVAX -3.9%, SIGA -2.2%, SVA +4.5%
Other Flu: APT +17.6%, CVM -3.4%, PURE +2.5%

Other Biotech
Big Winners: CPD +20.9, DSCO +22.5%
Losers: ARQL -5%, BSDM -4.6%, DYAX -11.8%, JAZZ -7.9%, NVGN -7.8%, ONXX -6.5%, QGLY -5%

SubMicro: GETA +26%, RGN -24%, TRMS -10%, VSCI -7%

New Intraday Highs:ILMN, SLXP, WYE

Disclosure: Long BCRX, BSDM, CVM, DNDN (sometimes I wonder why I bother - IF a stock goes up, they simply print more shares and clobber current investors so they can give themselves raises - what a SCAM!)

0 comments:

Disclaimer

This is not a solicitation or recommendation to buy or sell any stock. We are not registered investment advisors, and the site does not receive any compensation for any posts, endorsements, or listings. All investments carry risk, and your own individual situation should determine your strategy. Only invest funds you can afford to lose.

The Author at EZines

STEM CELLS EXPRESS

Visitor Map

Related Sites

World Markets Summary

Why We Invest

A company issuing stock gets it's money when the stock goes public, called IPO for Initial Public Offering. However, if the stock takes off due to future expectations, the company can capitalize by issuing more stock and raising money near the current price, so investing in these small biotech companies increases their chances of succeeding by raising enough additonal capital that they don't need to take on debt.

Then when promising drugs are approved and released, the subsequent income produced drives the stock price higher, and all investors and employees benefit and can either invest more in the industry or perhaps realize a goal in life.

1000 DVDs to See

About Me

My Photo
Artist, author, composer, still not dead yet in the Georgia woods, seeking wisdom in the silence of nature (plus a daily movie!) Constantly seeking and finding the "little gods that walk among us"
©2009, William L. Sinclair, All Rights Reserved

  © Blogger template 'Froggy' by Ourblogtemplates.com 2008

Back to TOP